Despite Trump’s fervent claims that Greenland’s 55,000 residents desire to join the US, both Denmark and Greenland’s local ...

Wall Street is pointing slightly lower in early trading but is on track to close the week with solid gains on healthy ...

Danish Prime Minister Mette Frederiksen posted on Facebook a picture of herself with her colleagues from Finland, Norway, and ...

Denmark is spending nearly 15 billion kroner to strengthen its defense in the Arctic and North Atlantic. This spending is part of a new agreement with the Faroese government and Greenland’s ...

The 27th Conference of the Parties (COP27) to the United Nation’s Framework Convent on Climate Change was held in Egypt from 6 to ... in the report was Novo Nordisk, which has set itself a ...

Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

A/S, a global healthcare company specializing in diabetes care and other chronic conditions, has been at the forefront of the rapidly expanding GLP-1 market. With a market capitalization of $376.79 ...

A/S, a global healthcare giant specializing in diabetes care and obesity treatment, continues to dominate the GLP-1 drug market alongside competitor Eli Lilly (NYSE:LLY). With a market capitalization ...

Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for ...

Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it gave to pharmacy firms, obesity charities and other professional bodies ...

Novo Nordisk announced phase 1b/2a clinical trial results for amycretin this morning. Patients taking the GLP-1 drug lost an average of 9.7% of their weight in 36 weeks. This is the best news Novo ...